ArticleBMC pharmacology & toxicology2025

Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System.

Xiaoling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.